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Abstract
Thymidine kinase (TK) has been validated as a serum-derived, tumour-associated marker
for a number of malignancies and estimation of TK activity in serum has proved useful for
clinical  diagnosis and monitoring of  therapy.  However,  the use of  this  biomarker in  the
clinical practice is constrained by the lack of an automatable easy-to-perform assay. We
have developed and validated a novel  HPLC-based assay for  measuring TK activity  in
biological samples. This assay is cheaper, easy to perform and does not depend on the
use of expensive antibodies or isotopes. In addition, it has comparable sensitivity with the
radioenzymatic assay used in the clinical  practice.  The assay has been evaluated with
samples from breast cancer patients.
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